Alzheimer Disease

Contributing journals to this collection:
JAMA & Archives Journals

Citations 561-570 of 695 total displayed.

Past content

Original Articles
Increased Neocortical Neurofibrillary Tangle Density in Subjects With Alzheimer Disease and Psychosis

Nuri B. Farber; Eugene H. Rubin; John W. Newcomer; Dorothy A. Kinscherf; J. Philip Miller; John C. Morris; John W. Olney; Daniel W. McKeel Jr
Arch Gen Psychiatry 2000; 57: 1165-1173. [Abstract] [Full text] [PDF]  

Basic Science Seminars in Neurology
Transgenic Mouse Models and Human Neurodegenerative Disorders

Han-Xiang Deng; Teepu Siddique
Arch Neurol 2000; 57: 1695-1702. [Extract] [Full text] [PDF]  

Original Contributions
Premorbid Reading Activity and Patterns of Cognitive Decline in Alzheimer Disease

Robert S. Wilson; David A. Bennett; David W. Gilley; Laurel A. Beckett; Lisa L. Barnes; Denis A. Evans
Arch Neurol 2000; 57: 1718-1723. [Abstract] [Full text] [PDF]  

Corrections
Cognitive-Behavioral Therapy, Imipramine, or Their Combination for Panic Disorder—Correction

JAMA 2000; 284: 2597. [Full text] [PDF]  

Original Contributions
Clues to Early Alzheimer Dementia in the Outpatient Setting

Cynthia Holzer; Gregg Warshaw
Arch Fam Med 2000; 9: 1066-1070. [Abstract] [Full text] [PDF]  

Original Contributions
Genetic Association of a Cystatin C Gene Polymorphism With Late-Onset Alzheimer Disease

Ulrich Finckh; Heinz von der Kammer; Joachim Velden; Tiana Michel; Barbara Andresen; Amy Deng; Jun Zhang; Tomas Müller-Thomsen; Kathrin Zuchowski; Gunnar Menzer; Ulrike Mann; Andreas Papassotiropoulos; Reinhard Heun; Jan Zurdel; Frederik Holst; Luisa Benussi; Gabriela Stoppe; Jochen Reiss; André R. Miserez; Hannes B. Staehelin; G. William Rebeck; Bradley T. Hyman; Giuliano Binetti; Christoph Hock; John H. Growdon; Roger M. Nitsch
Arch Neurol 2000; 57: 1579-1583. [Abstract] [Full text] [PDF]  

Original Contributions
Anti-inflammatory Drugs Protect Against Alzheimer Disease at Low Doses

G. Anthony Broe; David A. Grayson; Helen M. Creasey; Louise M. Waite; Barney J. Casey; Hayley P. Bennett; William S. Brooks; Glenda M. Halliday
Arch Neurol 2000; 57: 1586-1591. [Abstract] [Full text] [PDF]  

Original Articles
Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities: A Double-blind, Randomized, Placebo-Controlled Trial

Jamie S. Street; W. Scott Clark; Kimberley S. Gannon; Jeffrey L. Cummings; Frank P. Bymaster; Roy N. Tamura; Steven J. Mitan; Deborah L. Kadam; Todd M. Sanger; Peter D. Feldman; Gary D. Tollefson; Alan Breier; for the HGEU Study Group
Arch Gen Psychiatry 2000; 57: 968-976. [Abstract] [Full text] [PDF]  

Editorials
Is There a Connection Between the Concentration of Cholesterol Circulating in Plasma and the Rate of Neuritic Plaque Formation in Alzheimer Disease?

Robert W. Haley; John M. Dietschy
Arch Neurol 2000; 57: 1410-1412. [Extract] [Full text] [PDF]  

Original Contributions
Decreased Prevalence of Alzheimer Disease Associated With 3-Hydroxy-3-Methyglutaryl Coenzyme A Reductase Inhibitors

Benjamin Wolozin; Wendy Kellman; Paul Ruosseau; Gastone G. Celesia; George Siegel
Arch Neurol 2000; 57: 1439-1443. [Abstract] [Full text] [PDF]  

[First page]   [Previous page]   [Next page] Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70